IFN-γ induces aberrant CD49b+ NK cell recruitment through regulating CX3CL1: A novel mechanism by which IFN-γ provokes pregnancy failure

Cell Death and Disease

Volumn 5, Issue 11, 2014, Pages

  Li, Z Y ^a,b   Chao, H H ^a,b   Liu, H Y ^a   Song, Z H ^a,b   Li, L L ^a,b   Zhang, Y J ^a   Yang, Y ^a   Peng, J P ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; ALPHA2 INTEGRIN; CD3 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; GAMMA INTERFERON; JANUS KINASE 2; LECTIN; STAT1 PROTEIN; CHEMOKINE RECEPTOR; CX3CL1 PROTEIN, MOUSE; CX3CR1 PROTEIN, MOUSE; DOLICHOS BIFLORUS LECTIN RECEPTOR; JAK2 PROTEIN, MOUSE; LECTIN RECEPTOR; STAT1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DOLICHOS; DOLICHOS BIFLORUS; ENDOMETRIUM; FEMALE; FETUS RESORPTION; FETUS WASTAGE; INDUCED ABORTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; UPREGULATION; UTERUS; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; FETUS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PREGNANCY; SIGNAL TRANSDUCTION;

DOLICHOS BIFLORUS; MUS;

ABORTION, INDUCED; ANIMALS; CELLS, CULTURED; CHEMOKINE CX3CL1; CHEMOTAXIS; FEMALE; FETUS; GENE EXPRESSION REGULATION; INTEGRIN ALPHA2; INTERFERON-GAMMA; JANUS KINASE 2; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; PREGNANCY; RECEPTORS, CHEMOKINE; RECEPTORS, MITOGEN; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STROMAL CELLS; UTERUS;

EID: 84927926496     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.470     Document Type: Article

References (47)

1. Murphy SP, Tayade C, Ashkar AA, Hatta K, Zhang J, Croy BA. Interferon gamma in successful pregnancies. Biol Reprod 2009; 80: 848-859.
2. Liu Z, Chen Y, Yang Y, Peng JP. The effect on MHC class II expression and apoptosis in placenta by IFNgamma administration. Contraception 2002; 65: 177-184.
3. Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG. Control of fetal survival in CBAxDBA/2 mice by lymphokine therapy. J Reprod Fertil 1990; 89: 447-458.
4. Sun QH, Peng JP, Xia HF, Yang Y, Liu ML. Effect on expression of RT1-A and RT1-DM molecules of treatment with interferon-gamma at the maternal-fetal interface of pregnant rats. Hum Reprod 2005; 20: 2639-2647.
5. Liu Z, Sun QH, Yang Y, Liu JM, Peng JP. Effect of IFNgamma on caspase-3, Bcl-2 and Bax expression, and apoptosis in rabbit placenta. Cytokine 2003; 24: 201-209.
6. Sun QH, Peng JP, Xia HF, Yang Y. IFN-gamma promotes apoptosis of the uterus and placenta in pregnant rat and human cytotrophoblast cells. J Interferon Cytokine Res 2007; 27: 567-578.
7. Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA. Cytokine-dependent abortion in CBAxDBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J Immunol 1998; 160: 545-549.
8. Gendron RL, Nestel FP, Lapp WS, Baines MG. Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumour necrosis factor-alpha. J Reprod Fertil 1990; 90: 395-402.
9. Haddad EK, Duclos AJ, Antecka E, Lapp WS, Baines MG. Role of interferon-gamma in the priming of decidual macrophages for nitric oxide production and early pregnancy loss. Cell Immunol 1997; 181: 68-75.
10. Ashkar AA, Croy BA. Interferon-gamma contributes to the normalcy of murine pregnancy. Biol Reprod 1999; 61: 493-502.
11. Guimond MJ, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med 1998; 187: 217-223.
12. Arase H, Saito T, Phillips JH, Lanier LL. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol 2001; 167: 1141-1144.
13. Paffaro VA Jr., Bizinotto MC, Joazeiro PP, Yamada AT. Subset classification of mouse uterine natural killer cells by DBA lectin reactivity. Placenta 2003; 24: 479-488.
14. Chantakru S, Miller C, Roach LE, Kuziel WA, Maeda N, Wang WC et al. Contributions from self-renewal and trafficking to the uterine NK cell population of early pregnancy. J Immunol 2002; 168: 22-28.
15. Viola A, Luster AD. Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 2008; 48: 171-197.
16. Rossi DL, Hardiman G, Copeland NG, Gilbert DJ, Jenkins N, Zlotnik A et al. Cloning and characterization of a new type of mouse chemokine. Genomics 1998; 47: 163-170.
17. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91: 521-530.
18. Sciume G, De Angelis G, Benigni G, Ponzetta A, Morrone S, Santoni A et al. CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow. Blood 2011; 117: 4467-4475.
19. Ponzetta A, Sciume G, Benigni G, Antonangeli F, Morrone S, Santoni A et al. CX3CR1 regulates the maintenance of KLRG1+ NK cells into the bone marrow by promoting their entry into circulation. J Immunol 2013; 191: 5684-5694.
20. Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001; 107: 1173-1181.
21. Redline RW. Role of uterine natural killer cells and interferon gamma in placental development. J Exp Med 2000; 192: F1-F4.
22. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749-795.
23. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996; 379: 645-648.
24. Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 1999; 5: 444-447.
25. Gevrey JC, Isaac BM, Cox D. Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine). J Immunol 2005; 175: 3737-3745.
26. Platt JS, Hunt JS. Interferon-gamma gene expression in cycling and pregnant mouse uterus: temporal aspects and cellular localization. J Leukoc Biol 1998; 64: 393-400.
27. Ashkar AA, Di Santo JP, Croy BA. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000; 192: 259-270.
28. Haddad EK, Duclos AJ, Baines MG. Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. J Exp Med 1995; 182: 1143-1151.
29. Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 2005; 26: 44-62.
30. Guimond MJ, Luross JA, Wang B, Terhorst C, Danial S, Croy BA. Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice. Biol Reprod 1997; 56: 169-179.
31. Zhang JH, Yamada AT, Croy BA. DBA-lectin reactivity defines natural killer cells that have homed to mouse decidua. Placenta 2009; 30: 968-973.
32. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol 2004; 22: 405-429.
33. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006; 176: 1517-1524.
34. Kim S, Iizuka K, Kang HS, Dokun A, French AR, Greco S et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002; 3: 523-528.
35. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359-393.
36. Yadi H, Burke S, Madeja Z, Hemberger M, Moffett A, Colucci F. Unique receptor repertoire in mouse uterine NK cells. J Immunol 2008; 181: 6140-6147.
37. Chen Z, Zhang J, Hatta K, Lima PD, Yadi H, Colucci F et al. DBA-lectin reactivity defines mouse uterine natural killer cell subsets with biased gene expression. Biol Reprod 2012; 87: 81.
38. Keskin DB, Allan DS, Rybalov B, Andzelm MM, Stern JN, Kopcow HD et al. TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16-NK cells with similarities to decidual NK cells. Proc Natl Acad Sci USA 2007; 104: 3378-3383.
39. Hanna J, Wald O, Goldman-Wohl D, Prus D, Markel G, Gazit R et al. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16-human natural killer cells. Blood 2003; 102: 1569-1577.
40. Huang Y, Zhu XY, Du MR, Li DJ. Human trophoblasts recruited T lymphocytes and monocytes into decidua by secretion of chemokine CXCL16 and interaction with CXCR6 in the first-trimester pregnancy. J Immunol 2008; 180: 2367-2375.
41. Drake PM, Gunn MD, Charo IF, Tsou CL, Zhou Y, Huang L et al. Human placental cytotrophoblasts attract monocytes and CD56(bright) natural killer cells via the actions of monocyte inflammatory protein 1alpha. J Exp Med 2001; 193: 1199-1212.
42. Robinson LA, Nataraj C, Thomas DW, Cosby JM, Griffiths R, Bautch VL et al. The chemokine CX3CL1 regulates NK cell activity in vivo. Cell Immunol 2003; 225: 122-130.
43. Cook DN, Chen SC, Sullivan LM, Manfra DJ, Wiekowski MT, Prosser DM et al. Generation and analysis of mice lacking the chemokine fractalkine. Mol Cell Biol 2001; 21: 3159-3165.
44. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A et al. Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000; 20: 4106-4114.
45. Bernardini G, Sciume G, Bosisio D, Morrone S, Sozzani S, Santoni A. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood 2008; 111: 3626-3634.
46. Tan Y, Li M, Cox S, Davis MK, Tawfik O, Paria BC et al. HB-EGF directs stromal cell polyploidy and decidualization via cyclin D3 during implantation. Dev Biol 2004; 265: 181-195.
47. Chabtini L, Mfarrej B, Mounayar M, Zhu B, Batal I, Dakle PJ et al. TIM-3 regulates innate immune cells to induce fetomaternal tolerance. J Immunol 2013; 190: 88-96.